Get Defensive with These 3 Cash Flow Producing Machines

In This Article:

The ability of a given company to produce free cash flow is one factor you must consider when looking for stocks to buy. Holding stock in a firm with plenty of funds on hand could offer you peace of mind that it will be able to meet its debts with money left over to take advantage of expansion possibilities, distribute payouts to investors, or buy back shares.

Whether you’re aiming for stability or income, these three stocks are cash-flow-producing machines. Each is high on my watch list right now. But for long-term investors, I think these cash flow-producing stocks are worth considering on any significant market pullback moving forward. Let’s dive in.

CVS

CVS Health

$72.26

JNJ

Johnson & Johnson

$162.62

MCD

McDonald’s

$289.76

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

CVS Health

a man sitting behind a pile of cash
a man sitting behind a pile of cash

Source: Shutterstock

As far as companies with strong cash flow are concerned, CVS Health (NYSE:CVS) is certainly worth a look. CVS is a well-known large-cap company that has lost its appeal and popularity among many investors as social normalization trends gained momentum. Pandemic-driven tailwinds have faded. Accordingly, CVS stock has declined considerably from its peak seen last year. On a year-to-date basis, shares are down more than 20%. This decline is even worse since the beginning of 2022.

That said, I think there’s a reason why investors may view this as an opportunity to buy low and benefit from a rebound. Analysts on Wall Street share this sentiment, considering CVS a strong buy with an average price target of $112.10, representing a potential upside of 47%. This optimistic outlook suggests that CVS could be a valuable addition to any portfolio of blue-chip stocks.

CVS Health has expanded its business by taking advantage of its large retail footprint, adding America’s most significant pharmacy benefits management business. This has helped the company in other areas, such as health insurance benefits management, further strengthened by acquiring Aetna for around $78 billion in 2018. In the US, CVS Health has become among the top companies for managing medical insurance coverage.

CVS Health’s capability to offer various health benefits directly positions it to attain stable and substantial profit growth. Because of this, it is a desirable choice for traders seeking long-term potential.

Johnson & Johnson

7 Stocks to Buy Benefiting From Millennial Money
7 Stocks to Buy Benefiting From Millennial Money

Source: Shutterstock

The firm is responsible for producing several health and personal care product brands such as Neutrogena, Listerine, Tylenol, and Aveeno. These world-class brands have provided strong cash flow for Johnson & Johnson (NYSE:JNJ). Accordingly, investors shouldn’t be surprised to see the dividend performance of JNJ stock over the long term. For the past 60 consecutive years, Johnson & Johnson has raised its dividend. Companies without strong cash flow simply aren’t able to do so. And notably, investors anticipate the firm to do so once again in April. Currently, JNJ stock yields slightly less than 3%.